BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2 AND Treatment
13 results:

  • 1. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Selenite Inhibits Notch Signaling in Cells and Mice.
    Powers M; Liu L; Deemer D; Chen S; Scholl A; Yoshinaga M; Liu Z
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802299
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
    Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
    Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypes.
    Schindler EA; Gilbert MA; Piccoli DA; Spinner NB; Krantz ID; Loomes KM
    Am J Med Genet A; 2021 Mar; 185(3):719-731. PubMed ID: 33369123
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
    Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
    J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Noncoding Regulatory RNAs Network Driven by Circ-CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma.
    Wei Y; Chen X; Liang C; Ling Y; Yang X; Ye X; Zhang H; Yang P; Cui X; Ren Y; Xin X; Li H; Wang R; Wang W; Jiang F; Liu S; Ding J; Zhang B; Li L; Wang H
    Hepatology; 2020 Jan; 71(1):130-147. PubMed ID: 31148183
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway.
    Fang S; Liu M; Li L; Zhang FF; Li Y; Yan Q; Cui YZ; Zhu YH; Yuan YF; Guan XY
    Oncogene; 2019 May; 38(21):4061-4074. PubMed ID: 30696957
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combined antitumor effects of 1,25‑dihydroxy vitamin D3 and Notch inhibitor in liver cancer.
    Cai L; Luo L; Tang Z; Meng X
    Oncol Rep; 2018 Sep; 40(3):1515-1524. PubMed ID: 30015939
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of notch2 signaling.
    Huang G; Jiang H; Lin Y; Wu Y; Cai W; Shi B; Luo Y; Jian Z; Zhou X
    Cell Death Dis; 2018 May; 9(5):487. PubMed ID: 29706630
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.
    Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Konishi H; Shiozaki A; Morimura R; Ikoma H; Ochiai T; Okamoto K; Taniguchi H; Otsuji E
    Sci Rep; 2017 Jul; 7(1):5708. PubMed ID: 28720759
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differential effects of targeting Notch receptors in a mouse model of liver cancer.
    Huntzicker EG; Hötzel K; Choy L; Che L; Ross J; Pau G; Sharma N; Siebel CW; Chen X; French DM
    Hepatology; 2015 Mar; 61(3):942-52. PubMed ID: 25311838
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The effect of differentiating and apoptotic agents on notch signalling pathway in hepatoblastoma.
    Aktaş S; Zadeoğlulari Z; Erçetin P; Olgun N
    Hepatogastroenterology; 2010; 57(101):891-8. PubMed ID: 21033247
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.